Table of Contents
2019-2024 Global Pharmacogenomics (PGx) Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmacogenomics (PGx) Market Size 2014-2024
2.1.2 Pharmacogenomics (PGx) Market Size CAGR by Region
2.2 Pharmacogenomics (PGx) Segment by Type
2.2.1 Polymerase Chain Reaction (PCR)
2.2.2 Microarray
2.2.3 Sequencing
2.2.4 Other
2.3 Pharmacogenomics (PGx) Market Size by Type
2.3.1 Global Pharmacogenomics (PGx) Market Size Market Share by Type (2014-2019)
2.3.2 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type (2014-2019)
2.4 Pharmacogenomics (PGx) Segment by Application
2.4.1 Cardiovascular Diseases (CVD)
2.4.2 Central Nervous System (CNS)
2.4.3 Cancer/Oncology
2.4.4 Infectious Diseases
2.4.5 Other
2.5 Pharmacogenomics (PGx) Market Size by Application
2.5.1 Global Pharmacogenomics (PGx) Market Size Market Share by Application (2014-2019)
2.5.2 Global Pharmacogenomics (PGx) Market Size Growth Rate by Application (2014-2019)
3 Global Pharmacogenomics (PGx) by Players
3.1 Global Pharmacogenomics (PGx) Market Size Market Share by Players
3.1.1 Global Pharmacogenomics (PGx) Market Size by Players (2017-2019)
3.1.2 Global Pharmacogenomics (PGx) Market Size Market Share by Players (2017-2019)
3.2 Global Pharmacogenomics (PGx) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmacogenomics (PGx) by Regions
4.1 Pharmacogenomics (PGx) Market Size by Regions
4.2 Americas Pharmacogenomics (PGx) Market Size Growth
4.3 APAC Pharmacogenomics (PGx) Market Size Growth
4.4 Europe Pharmacogenomics (PGx) Market Size Growth
4.5 Middle East & Africa Pharmacogenomics (PGx) Market Size Growth
5 Americas
5.1 Americas Pharmacogenomics (PGx) Market Size by Countries
5.2 Americas Pharmacogenomics (PGx) Market Size by Type
5.3 Americas Pharmacogenomics (PGx) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pharmacogenomics (PGx) Market Size by Countries
6.2 APAC Pharmacogenomics (PGx) Market Size by Type
6.3 APAC Pharmacogenomics (PGx) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Pharmacogenomics (PGx) by Countries
7.2 Europe Pharmacogenomics (PGx) Market Size by Type
7.3 Europe Pharmacogenomics (PGx) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pharmacogenomics (PGx) by Countries
8.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type
8.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Pharmacogenomics (PGx) Market Forecast
10.1 Global Pharmacogenomics (PGx) Market Size Forecast (2019-2024)
10.2 Global Pharmacogenomics (PGx) Forecast by Regions
10.2.1 Global Pharmacogenomics (PGx) Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Pharmacogenomics (PGx) Forecast by Type
10.8 Global Pharmacogenomics (PGx) Forecast by Application
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Company Details
11.1.2 Pharmacogenomics (PGx) Product Offered
11.1.3 Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Abbott Laboratories News
11.2 Affymetrix, Inc.
11.2.1 Company Details
11.2.2 Pharmacogenomics (PGx) Product Offered
11.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Affymetrix, Inc. News
11.3 Assurex Health, Inc
11.3.1 Company Details
11.3.2 Pharmacogenomics (PGx) Product Offered
11.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Assurex Health, Inc News
11.4 Astrazeneca
11.4.1 Company Details
11.4.2 Pharmacogenomics (PGx) Product Offered
11.4.3 Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Astrazeneca News
11.5 GeneDX
11.5.1 Company Details
11.5.2 Pharmacogenomics (PGx) Product Offered
11.5.3 GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 GeneDX News
11.6 Illumina, Inc.
11.6.1 Company Details
11.6.2 Pharmacogenomics (PGx) Product Offered
11.6.3 Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Illumina, Inc. News
11.7 Laboratory Corporation of America Holdings
11.7.1 Company Details
11.7.2 Pharmacogenomics (PGx) Product Offered
11.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Laboratory Corporation of America Holdings News
11.8 Myriad Genetics, Inc.
11.8.1 Company Details
11.8.2 Pharmacogenomics (PGx) Product Offered
11.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Myriad Genetics, Inc. News
11.9 Pathway Genomics
11.9.1 Company Details
11.9.2 Pharmacogenomics (PGx) Product Offered
11.9.3 Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Pathway Genomics News
11.10 Pfizer, Inc
11.10.1 Company Details
11.10.2 Pharmacogenomics (PGx) Product Offered
11.10.3 Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Pfizer, Inc News
11.11 Qiagen, Inc.
11.12 Rocheg
11.13 Teva Pharmaceutical Industries Ltd.
11.14 Thermo Fisher Scientific
11.15 Transgenomic, Inc.
12 Research Findings and Conclusion
